Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study

[1]  R. Bai,et al.  Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis. , 2016, Atherosclerosis.

[2]  G. Lip,et al.  Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan. , 2015, Journal of the American College of Cardiology.

[3]  Mary Cushman,et al.  Atrial Fibrillation and Risk of ST-Segment–Elevation Versus Non–ST-Segment–Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study , 2015, Circulation.

[4]  David M Herrington,et al.  Atrial fibrillation and the risk of myocardial infarction. , 2015, JAMA internal medicine.

[5]  T. Chao,et al.  Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. , 2014, Heart rhythm.

[6]  Young Duk Song,et al.  Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System , 2014, Diabetes & metabolism journal.

[7]  L. Fauchier,et al.  Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project. , 2011, Chest.

[8]  C. Albert,et al.  Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. , 2011, JAMA.

[9]  N. Lakkis,et al.  Update on the Association of Inflammation and Atrial Fibrillation , 2010, Journal of cardiovascular electrophysiology.

[10]  G. Lip,et al.  Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients? , 2010, American Journal of Medicine.

[11]  R. Niska,et al.  Anticoagulation for Patients with Atrial Fibrillation in Ambulatory Care Settings , 2009, The Journal of the American Board of Family Medicine.

[12]  D. Levy,et al.  Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.

[13]  Fred S Apple,et al.  Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.

[14]  Gary King,et al.  Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference , 2007, Political Analysis.

[15]  B. Gersh,et al.  Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study , 2007, Circulation.

[16]  J. Seward,et al.  Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. , 2007, Journal of the American College of Cardiology.

[17]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[18]  M. Gheorghiade,et al.  Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. , 2006, European heart journal.

[19]  P. Shah,et al.  Mechanisms of plaque vulnerability and rupture. , 2003, Journal of the American College of Cardiology.

[20]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[21]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[22]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[23]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[24]  B. Gersh,et al.  The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.

[25]  P. Wolf,et al.  Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.

[26]  J. S. Lee,et al.  Cohort Profile Cohort Profile : The National Health Insurance Service – National Sample Cohort ( NHIS-NSC ) , South Korea , 2017 .

[27]  E. Benjamin,et al.  Status of the epidemiology of atrial fibrillation. , 2008, The Medical clinics of North America.

[28]  M. Keltai,et al.  Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion. , 1987, Circulation.